6. HUEB W., LOPES N, GERSH BJ, et al. Ten-year Follow-up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A Randomized Controlled Clinical Trial of 3 Therapeutic Strategies for Multivessel Coronary Artery Disease Circulation. 2010
;122:949-957.
7. BODEN WE, O'ROURKE RA, TEO KK, HARTIGAN PM, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med . 2007 ; 356 : 1503 –1516.
8. KOOMEN E.M., HUTTEN B.A., KELDER J.C., et al. Morbidity and mortality in patients waiting for coronary artery bypass surgery. Eur J Cardiothorac Surg2001;19:260-265.
9. MORGAN CD, SYKORA K, NAYLOR CD. Analysis of deaths while waiting for cardiac surgery among 29,293 consecutive patients in Ontario, Canada. Heart 1998, 79:345-34;
10. CESENA F.H.Y, CESAR LA, OLIVEIRA SM, LUZ PL. Cardiac complications during waiting for elective coronary artery bypass graft surgery: incidence, temporal distribution and predictive factors Eur J Cardiothorac Surg (2004) 25(2): 196-202 11. HADDAD N, BITTAR OJ, PEREIRA AA, et al. Conseqüências do Prolongamento do
Tempo de Espera em Pacientes Candidatos à Cirurgia Cardíaca. Arq Bras Cardiol 2002;78:452–8.
12. The global burden of disease: 2004 update. Geneva, World Health Organization, 2008.
13. Global status report on noncommunicable diseases 2010. Disponível em:
http://www.who.int/nmh/publications/ncd_report2010/en/index.html.
14. DUNCAN B.B., STEVENS A., ISER B.P., et al. Mortalidade por doenças crônicas no Brasil: situação em 2009 e tendências de 1991 a 2009. In: Silva-Junior JB, Morais Neto OL, Escalante JJ, Duarte EC, Garcia LP, Gil E, editors. Saúde Brasil 2010.
Brasília: Ministério da Saúde; 2011. p.117-134.
15. ABEGUNDE D. O., MATHERS C. D., ADAM T., et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007; 370 (9603):
1929-38.
16. SOARES G.P., BRUM J.D., OLIVEIRA G.M.M., KLEIN C.H., SOUZA E SILVA N.A.
Mortalidade por todas as causas e por doenças cardiovasculares em três estados do Brasil, 1980 a 2006. Rev Panam Salud Publica. 2010;28(4):258–66
17. OLIVEIRA GMM, KLEIN CH, SOUZA E SILVA NA. Mortalidade por doenças cardiovasculares em três estados do Brasil de 1980 a 2002. Rev Panam Salud Pública 2006; 19(2):85-93.
18. PRATA PR. The epidemiologic transition in Brazil. Cad Saude Publica.
1992;8(2):168–75.
19. YUNES J, RONCHEZEL VSC. Evolução da mortalidade geral, infantil e proporcional no Brasil. Rev Saude Publica. 1974;8(supl):3–48.
20. GO S. A. AND COLS, Heart Disease and Stroke Statistics--2013 Update : A Report From the American Heart Association Circulation. 2013;127:e6-e245
21. PINTO A.M.S., PINHEIRO R.S. Utilização de cirurgias cardíacas de alta complexidade no Estado do Rio de Janeiro numa perspectiva regionalizada: SIH-SUS – 1999 a 2007. Cad. Saúde Colet., 2010, Rio de Janeiro, 18 (3): 445-55.
22. WIJNS W, KOLH P, DANCHIN N, et al. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI),. Guidelines on myocardial revascularization. Eur Heart J. 2010 Oct;31(20):2501-55
23. MANESH R.P., GREGORY J.D., HIRSHFELD J.W., et al.
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012. Appropriate Use Criteria for Coronary Revascularization Focused Update. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography J Am Coll Cardiol . 2012; 59 (9) :857-881State Health Department Issues Report on Health Adult Cardiac Surgery outcomes in New York State 2003-2005. New York, 2008. 60p.
24. HANNAN EL, COZZENS K, SAMADASHVILI Z, et al,. Appropriateness of coronary revascularization for patients without acute coronary syndromes. J Am Coll Cardiol. 2012 May 22;59(21):1870-6.
25. PATEL MR, PETERSON ED, DAI D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886- 95. Erratum in: N Engl J Med.
2010;363(5):498.
26. FERREIRA R.M., SILVA N.A.S.S, SALIS L.H. Coronariografias sem Lesões Obstrutivas em Pacientes Referidos com Indicação para o Exame Rev Bras Cardiol.
2012;25(2):102-110
27. WILSON KO , TRANBAUGH R., JONATHAN D., et al. Myocardial Revascularization in New York State: Variations in the PCI-to-CABG Ratio and Their Implications J Am Heart Assoc. April 24, 2012
28. TU JV, PASCHOS CL, NAYLOR CD, CHEN E, et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med 1997;336:1500-5
29. CARVALHO, M.R.M.; SILVA, N.A..S.; KLEIN, C.H., OLIVEIRA G.M.M. Aplicação do EuroSCORE na cirurgia de revascularização miocárdica em hospitais públicos do Rio de Janeiro. Rev Bras Cir Cardiovasc 2010, vol.25, n.2, pp. 209-217.
30. BONARO S.N. , VILL D. , WIEDEMANN D., FISCHLER K. , et al. Major risk stratification models do not predict perioperative outcome after coronary artery bypass grafting in patients with previous percutaneous intervention. Eur J Cardiothorac Surg ( 2011 ) 39 ( 6 ): e164 - E169
31. FITCH K., AND COL. The RAND/UCLA Appropriateness Method User's Manual, Santa Monica, Calif.: RAND Corporation, MR-1269-DG-XII/RE, 2001:http://www.rand.org/pubs/monograph_reports/MR1269
32. RJ GIBBONS, J. ABRAMS, K. CHATTERJEE et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003 Jan 1;41(1):159-68
33. L. CAMPEAU. Grading of angina pectoris. Circulation, 54 (1976), pp. 522–523.
34. O’CONNOR TG, OLMSTEAD EM, et al. Appropriateness of Coronary Artery Bypass Graft Surgery Performed in Northern New England . J Am Coll Cardiol 2008;51:2323–8)
35. FITCH K et al. European criteria for the appropriateness and necessity of coronary revascularization procedures. Eur J Cardiothorac Surg. 2000 Oct;18(4):380-7.
36. NALYSNYK L, FAHRBACH K, REYNOLDS MW, et al. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart. 2003 Jul; 89(7):767-72.
37. NORONHA SC, MARTINS M, TRAVASSOS C, et al. Aplicação da mortalidade hospitalar após realização de cirurgia de revascularização do miocárdio para monitoramento do cuidado hospitalar. Cad Saúde Publica. 2004 ;20 (supll2):S322-S330
38. NASHEF SAM, ROQUES F, MICHEL P, et al. Coronary surgery in Europe:
comparison of the national subsets of the European System for Cardiac Operative Risk Evaluation database. Eur J Cardiothorac Surg. 2000; 17: 396-9.
39. PIEGAS, L.S.; BITTAR, OLÍMPIO J., NOGUEIRA V. and HADDAD, N. Cirurgia de revascularização miocárdica: resultados do Sistema Único de Saúde. Arq. Bras.
Cardiol. 2009, vol.93, n.5, pp. 555-560 .